|
🐜
|
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
57 auth.
S. Al-Batran,
N. Homann,
C. Pauligk,
T. Goetze,
J. Meiler,
S. Kasper,
H. Kopp,
F. Mayer,
G. Haag,
K. Luley,
U. Lindig,
W. Schmiegel,
M. Pohl,
J. Stoehlmacher,
G. Folprecht,
...
S. Probst,
N. Prasnikar,
W. Fischbach,
R. Mahlberg,
J. Trojan,
M. Koenigsmann,
U. Martens,
P. Thuss-Patience,
M. Egger,
A. Block,
V. Heinemann,
G. Illerhaus,
M. Moehler,
M. Schenk,
F. Kullmann,
D. Behringer,
M. Heike,
D. Pink,
C. Teschendorf,
Carmen Löhr,
H. Bernhard,
G. Schuch,
V. Rethwisch,
L. F. V. Weikersthal,
J. Hartmann,
M. Kneba,
S. Daum,
K. Schulmann,
J. Weniger,
S. Belle,
T. Gaiser,
F. Oduncu,
M. Güntner,
W. Hozaeel,
Alexander Reichart,
E. Jäger,
T. Kraus,
S. Mönig,
W. Bechstein,
M. Schuler,
H. Schmalenberg,
R. Hofheinz
|
10 |
2019 |
10
🐜
|
|
🐜
|
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.
20 auth.
S. Al-Batran,
J. Hartmann,
S. Probst,
H. Schmalenberg,
S. Hollerbach,
R. Hofheinz,
V. Rethwisch,
G. Seipelt,
N. Homann,
G. Wilhelm,
...
G. Schuch,
J. Stoehlmacher,
H. Derigs,
S. Hegewisch‐Becker,
J. Grossmann,
C. Pauligk,
A. Atmaca,
C. Bokemeyer,
A. Knuth,
E. Jäger
|
9 |
2008 |
9
🐜
|
|
🐜
|
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multice
40 auth.
S. Al-Batran,
R. Hofheinz,
C. Pauligk,
H. Kopp,
G. Haag,
K. Luley,
J. Meiler,
N. Homann,
S. Lorenzen,
H. Schmalenberg,
S. Probst,
M. Koenigsmann,
M. Egger,
N. Prasnikar,
K. Caca,
...
J. Trojan,
U. Martens,
A. Block,
W. Fischbach,
R. Mahlberg,
M. Clemens,
G. Illerhaus,
K. Zirlik,
D. Behringer,
W. Schmiegel,
M. Pohl,
M. Heike,
U. Ronellenfitsch,
M. Schuler,
W. Bechstein,
A. Königsrainer,
T. Gaiser,
P. Schirmacher,
W. Hozaeel,
Alexander Reichart,
T. Goetze,
M. Sievert,
E. Jäger,
S. Mönig,
A. Tannapfel
|
9 |
2016 |
9
🐜
|
|
🐜
|
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.
20 auth.
H. Oettle,
Stefan Post,
P. Neuhaus,
K. Gellert,
J. Langrehr,
K. Ridwelski,
H. Schramm,
J. Fahlke,
C. Zuelke,
C. Burkart,
...
K. Gutberlet,
E. Kettner,
H. Schmalenberg,
K. Weigang-Koehler,
W. Bechstein,
M. Niedergethmann,
I. Schmidt-Wolf,
L. Roll,
B. Doerken,
H. Riess
|
8 |
2007 |
8
🐜
|
|
🐜
|
Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial
28 auth.
S. Al-Batran,
N. Homann,
C. Pauligk,
G. Illerhaus,
U. Martens,
J. Stoehlmacher,
H. Schmalenberg,
K. Luley,
N. Prasnikar,
M. Egger,
S. Probst,
H. Messmann,
M. Moehler,
W. Fischbach,
J. Hartmann,
...
F. Mayer,
H. Höffkes,
M. Koenigsmann,
D. Arnold,
T. Kraus,
Kersten Grimm,
Stefan Berkhoff,
S. Post,
E. Jäger,
W. Bechstein,
U. Ronellenfitsch,
S. Mönig,
R. Hofheinz
|
8 |
2017 |
8
🐜
|
|
🐜
|
Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial
29 auth.
T. Götze,
N. Homann,
H. Schmalenberg,
HG Kopp,
GM Haag,
K. Luley,
W. Schmiegel,
G. Folprecht,
S. Probst,
N. Prasnikar,
P. Thuss-Patience,
W. Fischbach,
J. Trojan,
M. Koenigsmann,
C. Pauligk,
...
T. Kraus,
A. Battmann,
A. Paul,
S. Mönig,
W. Bechstein,
T. Gaiser,
A. Tannapfel,
E. Jäger,
M. Schuler,
U. Lindig,
M. Pohl,
S. Kasper,
RD Hofheinz,
S. Al-Batran
|
7 |
2017 |
7
🐜
|
|
🐜
|
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI
41 auth.
S. Al-Batran,
T. Goetze,
D. W. Mueller,
A. Vogel,
Michael Winkler,
S. Lorenzen,
A. Novotny,
C. Pauligk,
N. Homann,
T. Jungbluth,
Christoph Reissfelder,
K. Caca,
S. Retter,
E. Horndasch,
J. Gumpp,
...
C. Bolling,
K. Fuchs,
W. Blau,
W. Padberg,
M. Pohl,
A. Wunsch,
P. Michl,
F. Mannes,
M. Schwarzbach,
H. Schmalenberg,
Michael Hohaus,
C. Scholz,
C. Benckert,
J. R. Knorrenschild,
V. Kanngiesser,
T. Zander,
H. Alakus,
R. Hofheinz,
C. Roedel,
M. Shah,
M. Sasako,
D. Lorenz,
J. Izbicki,
W. Bechstein,
H. Lang,
S. Moenig
|
7 |
2017 |
7
🐜
|
|
🐜
|
Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma.
29 auth.
U. Kaiser,
Irmgard Uebelacker,
U. Abel,
J. Birkmann,
L. Trümper,
H. Schmalenberg,
T. Karakas,
B. Metzner,
D. Hossfeld,
H. Bischoff,
A. Franke,
M. Reiser,
P. Müller,
L. Mantovani,
M. Grundeis,
...
F. Rothmann,
C. von Seydewitz,
R. Mesters,
E. Steinhauer,
D. Krahl,
K. Schumacher,
M. Kneba,
M. Baudis,
N. Schmitz,
R. Pfab,
H. Köppler,
R. Parwaresch,
M. Pfreundschuh,
K. Havemann
|
7 |
2002 |
7
🐜
|
|
🐜
|
Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer
7 auth.
S. Lorenzen,
C. Pauligk,
N. Homann,
H. Schmalenberg,
F. Tauchert,
E. Jäger,
...
Salah-Eddin Al-Batran
|
6 |
2012 |
6
🐜
|
|
🐜
|
Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
10 auth.
A. Wunderlich,
M. Kloess,
M. Reiser,
C. Rudolph,
L. Truemper,
S. Bittner,
...
H. Schmalenberg,
R. Schmits,
M. Pfreundschuh,
M. Loeffler
|
6 |
2003 |
6
🐜
|
|
🐜
|
Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer
13 auth.
J. Inhestern,
K. Oertel,
V. Stemmann,
H. Schmalenberg,
A. Dietz,
N. Rotter,
J. Veit,
M. Görner,
H. Sudhoff,
C. Junghanss,
...
C. Wittekindt,
K. Pachmann,
O. Guntinas-Lichius
|
5 |
2015 |
5
🐜
|
|
🐜
|
Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials
11 auth.
A. Wagner,
P. Buechner-Steudel,
M. Moehler,
H. Schmalenberg,
R. Behrens,
J. Fahlke,
...
A. Wein,
S. Behl,
O. Kuss,
G. Kleber,
W. Fleig
|
5 |
2009 |
5
🐜
|
